Does ATEZOLIZUMAB Cause Hepatic function abnormal? 490 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 490 reports of Hepatic function abnormal have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 1.5% of all adverse event reports for ATEZOLIZUMAB.
490
Reports of Hepatic function abnormal with ATEZOLIZUMAB
1.5%
of all ATEZOLIZUMAB reports
96
Deaths
235
Hospitalizations
How Dangerous Is Hepatic function abnormal From ATEZOLIZUMAB?
Of the 490 reports, 96 (19.6%) resulted in death, 235 (48.0%) required hospitalization, and 16 (3.3%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 490 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ATEZOLIZUMAB Alternatives Have Lower Hepatic function abnormal Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN